Đang chuẩn bị liên kết để tải về tài liệu:
The Breast Cancer to Bone (B2B) Metastases Research Program: A multi-disciplinary investigation of bone metastases from breast cancer

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Bone is the most common site of breast cancer distant metastasis, affecting 50–70 % of patients who develop metastatic disease. Despite decades of informative research, the effective prevention, prediction and treatment of these lesions remains elusive. |

TÀI LIỆU LIÊN QUAN

Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients

Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer

The Breast Cancer to Bone (B2B) Metastases Research Program: A multi-disciplinary investigation of bone metastases from breast cancer

Disentangling the body weight-bone mineral density association among breast cancer survivors: An examination of the independent roles of lean mass and fat mass

Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy

Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients

A computational model to predict bone metastasis in breast cancer by integrating the dysregulated pathways

IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells

Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: A large cohort retrospective study

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: Study protocol for a randomised phase III trial (STEREO-OS)
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.